Bioresorbable stent with beneficial agent reservoirs
First Claim
1. A bioresorbable drug delivery stent comprising:
- a substantially cylindrical expandable stent formed of a plurality of struts of a bioresorbable material;
a plurality of openings formed in the stent struts; and
a beneficial agent matrix loaded within the plurality of openings, the beneficial agent matrix comprising a bioresorbable matrix material.
3 Assignments
0 Petitions
Accused Products
Abstract
A bioresorbable drug delivery stent includes a substantially cylindrical expandable stent formed of a bioresorbable or bioresorbable material and a plurality of reservoirs or openings formed in the stent containing a beneficial agent matrix comprising a bioresorbable material and a drug. The bioresorbable stent material can be a bioresorbable metal alloy, a bioresorbable polymer, or other bioresorbable material which has sufficient structural integrity to support a lumen, such as a blood vessel lumen for a predetermined period of time. The reservoirs containing the beneficial agent matrix allow delivery of the beneficial agent, such as an anti-restenotic drug, for an administration period which is generally equal to or less than a time that the bioresorbable stent is retained in the lumen. The beneficial agent matrix may include one or more bioresorbable polymers in combination with one or more therapeutic agents or drugs and the structure of the beneficial agent matrix can be programmed to achieve a desired release profile for the drug(s) and a desired administration period.
228 Citations
39 Claims
-
1. A bioresorbable drug delivery stent comprising:
-
a substantially cylindrical expandable stent formed of a plurality of struts of a bioresorbable material;
a plurality of openings formed in the stent struts; and
a beneficial agent matrix loaded within the plurality of openings, the beneficial agent matrix comprising a bioresorbable matrix material. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
- 15. A bioresorbable drug delivery stent comprising a substantially cylindrical expandable stent body formed of a bioresorbable material and a plurality of openings formed in the stent body containing a beneficial agent matrix comprising a bioresorbable polymer and a drug, wherein the bioresorbable material of the stent body is a different material than the bioresorbable polymer of the beneficial agent matrix.
-
28. A method of reducing restenosis with a bioresorbable drug delivery stent, the method comprising:
-
providing a drug delivery bioresorbable stent having a dosage of anti-restenotic drug arranged within a plurality of openings in the stent without coating an exterior surface of the stent with the anti-restonotic drug;
implanting the stent within an artery of a patient; and
delivering the anti-restenotic drug from the stent to the artery at a minimum release rate of 1 percent of the total dosage of the drug on the stent per day throughout an entire administration period from the time of implantation of the stent until the time that substantially all the drug is released from the stent. - View Dependent Claims (29, 30, 31)
-
-
32. A bioresorbable drug delivery stent comprising:
-
a substantially cylindrical expandable stent formed of a bioresorbable material;
a plurality of openings formed in the stent;
a beneficial agent matrix loaded within the plurality of openings, the beneficial agent matrix comprising a drug, and wherein the beneficial agent matrix is arranged such that the beneficial agent matrix does not block access of fluid from an environment surrounding the stent to the bioresorbable stent material. - View Dependent Claims (33, 34, 35, 36, 37, 38, 39)
-
Specification